Adherence to GLP-1s better than earlier reported Source: Marshall, LZ et al Trends in 1-year persistence and adherence among initiators of high-potency, weight lossindicated glucagon-like peptide 1 receptor agonists, J Man Care Pharm February 27, 2026 Multiple studies have reported low adherence to GLP-1 medications to treat obesity, and some have cited this as a reason why employers should not cover these medications
Similar content being viewed by others Introduction Weight loss can arise in a variety of clinical contexts, including chronic diseases such as anorexia nervosa and inflammatory bowel disease, as well as from active medical interventions like bariatric surgery and pharmacotherapy
Consider timing : Taking L-Carnitine 30 to 60 minutes before training can maximize its potential to increase the use of fats as an energy source
I ordered them when you posted about the new pharmacy
Medical Comorbidities, Biomarkers, and Provider Decision-Making Postpartum thyroid disorders (postpartum thyroiditis affects 510% of women), gestational diabetes history, and preeclampsia all influence GLP-1 safety and timing